Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.
Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ.
BMJ Open. 2019 Jan 21;9(1):e023600. doi: 10.1136/bmjopen-2018-023600.
A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
Goodman CW, Brett AS.
JAMA Intern Med. 2019 May 1;179(5):695-701. doi: 10.1001/jamainternmed.2019.0086.
Pregabalin for neuropathic pain in adults.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA.
Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3.
Potential novel therapeutic strategies for neuropathic pain.
Du Z, Zhang J, Han X, Yu W, Gu X.
Front Mol Neurosci. 2023 Apr 21;16:1138798. doi: 10.3389/fnmol.2023.1138798. eCollection 2023.
Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all?
Markman JD, Baron R, Gewandter JS.
Drug Discov Today. 2018 Nov;23(11):1904-1909. doi: 10.1016/j.drudis.2018.06.004. Epub 2018 Jun 9.
Predictors of Persistent Neuropathic Pain--A Systematic Review.
Boogaard S, Heymans MW, de Vet HC, Peters ML, Loer SA, Zuurmond WW, Perez RS.
Pain Physician. 2015 Sep-Oct;18(5):433-57.
Pain Clinic in Tibet, China: A Single-Center Retrospective Study.
Shen L, Zhang X, Dawawuzhu, Labaciren, Zhang Y, Xu Z, Huang Y.
Pain Res Manag. 2019 Jan 14;2019:9161906. doi: 10.1155/2019/9161906. eCollection 2019.
Gabapentin as a potential option for treatment of sciatica.
Grice GR, Mertens MK.
Pharmacotherapy. 2008 Mar;28(3):397-402. doi: 10.1592/phco.28.3.397.
[Characteristics of clinical application of electroacupuncture therapy for peripheral neuropathy based on data mining].
Zhang ZD, Wang RQ, Liu JX, Li XF, Zhang X, Du YZ, Gao F, Jia CS, Xing HJ.
Zhen Ci Yan Jiu. 2021 Mar 25;46(3):240-7. doi: 10.13702/j.1000-0607.200638.
Relief from chronic pain by low power laser irradiation.
Walker J.
Neurosci Lett. 1983 Dec 30;43(2-3):339-44. doi: 10.1016/0304-3940(83)90211-2.
